Breakthrough New Pain Data from ASRA, November 2025 | Now Available to VA Providers
Get exclusive early access to the latest clinical evidence on BioWave, presented at ASRA battlefield trauma results and large-scale real-world chronic pain outcomes.
Trusted for
15+ Years
Clinically
Proven
25 Years of
Pain relief
New ASRA, November 2025 Clinical Data, Now Available for VA Providers
Download two newly presented research posters featuring:
- Outcomes from 48 Ukrainian soldiers with battlefield injuries
- Data from 10,407 chronic pain patients using BioWave at home
- Significant reductions in pain, improved mobility, QoL, sleep, and reduced medication use
- For VA clinicians and staff
Federal Supply Schedule Contract # V797D-70205
Why BioWave
hours
0
of pain relief on average following a 30-minute treatment1
0
%
of patients reported an improvement in quality of life after using BioWave for two weeks1
point
0
average reduction in pain score (0-10 scale) after using BioWave for two weeks2
0
%
of patients reduced or eliminated their pain medication consumption after using BioWave for two weeks1
For patients battling chronic pain who want to avoid opioids or surgery, BioWave offers a proven solution.
When other therapies fall short, BioWave delivers safe, noninvasive,
drug-free relief that lasts, helping people regain mobility and quality of life.
- Easy to use, no programming
- Comfortable treatment – high compliance
- Improved ADLs and increased independence
- Opioid free
- Safe to use at home (auto shut off)
